Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Hollis Eden Pharmaceuticals Inc. (HEPH) -- Ignore unavailable to you. Want to Upgrade?

To: BDR who wrote (31)	3/19/1998 2:08:00 PM
From: Biojunkie	Read Replies (4) \| Respond to of 138

Thanks for providing us with your insight and understanding of bioavailability (how much drug gets into the bloodstream)with regards to the hormone which you've mentioned is available at your corner drug/healthfood store. That product is essentially harmless and ineffective. In interpreting the literature surrounding this company's technology, it appears their lead drug candidate was discovered through research conducted on different analogues of the hormone you mentioned, which were made to be bioavailable. Wouldn't it be a shame if you shorted a company that may have a less expensive, easier to use drug that dramatically inhibits HIV replication? I would do your homework before you assume that this is stock manipulation.